Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?

Autor:	Mason, M. D., van der Kwast, T. H., Mottet, N., Oprea-Lager, D. E., Rouvière, O.
Přispěvatelé:	Radiology and nuclear medicine, CCA - Imaging and biomarkers, Pathology
Rok vydání:	2022
Předmět:	Male SDG 3 - Good Health and Well-being Urology Humans Prostatic Neoplasms Neoplasm Staging
Zdroj:	European Urology, 81(4), 319-322. Elsevier EAU-EANM-ESTRO-ESUR-ISUP-SIOG Prostate Cancer Guidelines Panel 2022, ' Modern Imaging in Prostate Cancer : Do We Treat Patients, or Their Scans? ', European Urology, vol. 81, no. 4, pp. 319-322 . https://doi.org/10.1016/j.eururo.2022.01.002 European Urology, 81(4), 319-322
ISSN:	0302-2838
DOI:	10.1016/j.eururo.2022.01.002
Popis:	New imaging techniques are more sensitive in prostate cancer and reveal sites of disease that may never have been seen with conventional imaging, resulting in stage migration and potentially a change in the clinical management. Until long-term data provide a better understanding of the natural history of the disease defined by more sensitive imaging, patients and clinicians should recognise the considerable uncertainty about whether these improve outcomes. It is hoped that the next iteration of the TNM classification will recognise the problem in some way.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e812eee3d090528adedc719bcb15c87 https://doi.org/10.1016/j.eururo.2022.01.002 Zobrazit plný text záznamu Full Text from ScienceDirect